Cambridge Protein Arrays
Private Company
Funding information not available
Overview
Cambridge Protein Arrays is a specialized proteomics tools and services company operating from the Babraham Research Campus in Cambridge, UK. Its core asset is the HuProt™ Human Proteome Microarray, a platform containing over 20,000 individually printed proteins representing more than 80% of the human proteome, used for applications like antibody validation, autoantibody discovery, and interaction profiling. The company generates revenue through direct sales of these arrays and by offering expert screening services, positioning itself as a key European partner for high-throughput protein interaction studies. It also organizes the Alpbach Affinity Proteomics Workshop, reinforcing its role as a thought leader in the antibody validation space.
Technology Platform
HuProt™ Human Proteome Microarray platform, featuring over 20,000 full-length human proteins printed on a slide for high-throughput, proteome-wide interaction screening.
Opportunities
Risk Factors
Competitive Landscape
CPA competes with other specialized protein array providers like CDI Labs (US) and potentially divisions of large life science tools companies (e.g., Thermo Fisher, Merck) that offer protein arrays. Its key differentiator is the claimed comprehensiveness (full-length, >80% proteome coverage) of the HuProt v4 array and its integrated service expertise in array-based screening.